anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

206,461-206,520 of 319,975

filter-aware
03
The slide uses a side-by-side comparison framework to highlight the versatility of the PS-based delivery technology.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
04
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
The slide uses a process diagram to show the self-assembly of lipoplexes into solid particles.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
06
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
07
Technical mechanism slide describing biological targeting and delivery pathways.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style visualization to represent drug development stages.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
09
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem1 hit
10
Uses WHO priority pathogen list as an external validation/market driver for the company's pipeline.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a 'Before-After-Bridge' style logic to frame the solution.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
Uses a chevron-based process diagram to illustrate lifecycle management.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide uses a process flow diagram to present five key clinical outcomes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
14
Data shows survival percentages with n/N counts below each bar group.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based visualization to demonstrate clinical efficacy.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
16
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
17
IFIs stands for Invasive Fungal Infections.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
18
The slide presents individual patient case studies to demonstrate clinical efficacy and safety in complex, treatment-refractory cases.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
19
The slide provides anecdotal evidence of efficacy and safety in compassionate use cases.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
20
The slide uses a high-key, clean aesthetic typical of biopharma corporate decks.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
21
The slide uses a chevron-based process flow to represent maturity stages: Proven, Under Evaluation, and Future.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
Includes fluorescence microscopy images as visual proof of biological activity (GFP expression) over time.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
Shows both in vivo (IP) and ex vivo (IM) imaging results with corresponding time-course data.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
24
The slide highlights a specific partnership and its strategic benefits.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
25
The slide uses a grid-based timeline format to track specific technical achievements and future partnership goals.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Team1 hit
28
The slide combines financial runway, a timeline of upcoming catalysts, and a summary of the investment thesis (floor vs upside).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
01
Slide 1
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
02
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
03
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
04
The chart compares 2022 quarterly volumes against 2023 Q1 volume.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
05
Includes a dual-axis line chart and a summary table of economic projections.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
06
The chart compares 2022 and 2023 quarterly container volumes, with a specific callout for the Q1 YoY decline.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
07
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
08
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
09
The chart shows a comparison of Q1 2023 vs Q1 2022, with subsequent 2022 quarters for context.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
10
The chart shows 2022 quarterly data and a single 2023 Q1 data point.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
11
The chart shows quarterly equity income for 2022 (blue) and Q1 2023 (orange).Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
12
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
13
Includes GAAP EPS, depreciation, and EBITDA metrics.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
14
The chart illustrates the bridge between cash generated and cash spent/invested.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
15
Includes specific debt prepayment details and share repurchase activity.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
16
Provides financial details on cash deposits, tax refunds, and milestone payment funding.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
17
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
18
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
19
Includes a table showing the bridge from Net Income to EBITDA for Q1 2023, Q1 2022, the change, and the last twelve months.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
01
Slide 1
Includes date 'MAY 2023' in top right corner.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations 1 hit
02
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations 1 hit
03
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations 1 hit
04
Includes a footer disclaimer regarding GAAP reconciliation and a brand logo strip.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide highlights operational improvements and growth metrics for Soho House & Co.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
Includes margin percentages for House-Level and Other Contribution metrics.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
The slide uses a standard waterfall bridge to explain revenue variance.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · Financials1 hit
12
Includes a list of 'Expenses not added back' for both periods.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · Financials1 hit
13
Includes a table of cash/debt metrics and a bar chart showing loan expiry profile.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · Financials1 hit
14
Membership Collective Group | Results Presentation Deck | 32 slidesMembership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · Financials1 hit
15
Includes footnotes regarding FX headwinds and EBITDA adjustments.Membership Collective Group | Results Presentation Deck | 32 slides · Soho House & Co Inc.
Conference presentation Investor relations Beat · Financials1 hit